跳至主要内容
临床试验/ITMCTR2100005423
ITMCTR2100005423已完成1 期

Xingnao Kaiqiao acupuncture treatment of sleep disorders after stroke

tianjin academy of traditional chinese medicine affiliated hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 80(—)
性别
All

入选标准

  • (1) Meet the above-mentioned diagnostic criteria of Chinese and Western medicine for stroke and insomnia and the diagnostic criteria for syndromes;
  • (2) No history of insomnia and use of various psychotropic drugs before stroke;
  • (3) People who sleep less than 6 hours at night after a stroke, frequently wake up from sleep, or stay awake at night; more than 3 times a week for more than 1 month;
  • (4) The Pittsburgh Sleep Quality Score (PSQI) exceeds 7 points;
  • (5) During the recovery period from 15 days to 180 days after the onset of stroke;
  • (6) Unconsciousness obstacles, no obvious intelligence, language understanding and expression obstacles, able to basically complete various scale tests independently;
  • (7) NIHSS score = 15 points;
  • (8) 45 years old = age = 80 years old;
  • (9) Informed consent of patients.
  • Those who meet the above criteria at the same time can be selected.

排除标准

  • (1) Patients allergic to estazolam;
  • (2) Insomnia caused by other diseases or living habits (alcoholism, drug dependence, etc.); or those who are dependent on tranquillizers;
  • (3) Those with severe mental symptoms;
  • (4) Those who have participated in clinical research of other drugs in the past month, or those who have used related psychosedatives in the past two weeks;
  • (5) Severe heart, liver (ALT, AST exceeding 50% of the upper limit of normal), kidney (BUN exceeding 20% ??of the upper limit of normal, Cr exceeding the upper limit of normal), hematopoietic system and metabolic system and other serious diseases or other People with severe diseases in various systems;
  • (6) Women who are breast-feeding, pregnant, or likely to become pregnant during the trial period;
  • (7) Poor compliance after enrollment, privately combined use of drugs or treatments not permitted by the trial, serious adverse reactions during treatment, loss to follow-up or refusal to continue to participate in the trial.
  • Those that meet one of the above will be excluded.

研究者

相似试验